See more : Seamless Green China (Holdings) Limited (8150.HK) Income Statement Analysis – Financial Results
Complete financial analysis of Amicogen, Inc. (092040.KQ) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Amicogen, Inc., a leading company in the Biotechnology industry within the Healthcare sector.
- AJ Advance Technology Public Company Limited (AJA.BK) Income Statement Analysis – Financial Results
- Moon Environment Technology Co.,Ltd. (000811.SZ) Income Statement Analysis – Financial Results
- Athene Holding Ltd. (ATH-PA) Income Statement Analysis – Financial Results
- LCC Infotech Limited (LCCINFOTEC.NS) Income Statement Analysis – Financial Results
- Toppan Inc. (7911.T) Income Statement Analysis – Financial Results
Amicogen, Inc. (092040.KQ)
About Amicogen, Inc.
Amicogen, Inc. operates as an industrial biotechnology company in South Korea and internationally. The company offers specialty enzymes, including CX, SP, etc. for pharmaceutical, food, chemical, and energy industries. It also provides new bio-ingredients, such as N-acetylglucosamine for skin moisturizing and joint health; pinitol/D-chiro-inositol; collagen peptide and collagen tripeptide for skin and health; chitoslim and chitosan oligosaccharides; and lactic acid bacteria, as well as fucoxanthin, curezyme, food enzyme, and bamboo salt. In addition, the company offers K-nutra, a healthcare brand; and KeyClean, a disinfectant brand. Further, it provides protein purification resins. The company was founded in 2000 and is headquartered in Jinju-si, South Korea.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 159.90B | 144.30B | 124.88B | 115.86B | 115.18B | 94.52B | 73.67B | 68.97B | 32.46B | 27.33B | 23.18B |
| Cost of Revenue | 104.78B | 101.80B | 83.06B | 74.18B | 69.48B | 65.27B | 49.92B | 45.74B | 20.70B | 13.63B | 11.29B |
| Gross Profit | 55.13B | 42.49B | 41.82B | 41.68B | 45.70B | 29.25B | 23.74B | 23.23B | 11.75B | 13.70B | 11.89B |
| Gross Profit Ratio | 34.47% | 29.45% | 33.48% | 35.97% | 39.68% | 30.94% | 32.23% | 33.68% | 36.21% | 50.12% | 51.31% |
| Research & Development | 13.78B | 12.44B | 10.84B | 6.28B | 5.38B | 5.28B | 4.93B | 3.33B | 2.65B | 1.05B | 821.51M |
| General & Administrative | 6.94B | 4.48B | 12.82B | 3.63B | 327.00M | 497.22M | 258.88M | 225.92M | 96.40M | 30.78M | 39.77M |
| Selling & Marketing | 8.51B | 12.09B | 5.61B | 14.37B | 10.56B | 6.94B | 3.94B | 3.70B | 1.86B | 692.09M | 599.65M |
| SG&A | 39.04B | 34.98B | 35.60B | 32.75B | 42.92B | 21.74B | 16.92B | 15.73B | 6.77B | 3.08B | 2.13B |
| Other Expenses | 0.00 | 594.50M | 242.33M | -282.02M | -15.03M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 53.07B | 47.42B | 46.44B | 39.31B | 48.31B | 27.02B | 21.85B | 19.05B | 9.42B | 4.61B | 2.93B |
| Cost & Expenses | 157.85B | 149.22B | 129.51B | 113.49B | 117.79B | 92.30B | 71.77B | 64.79B | 30.12B | 18.24B | 14.22B |
| Interest Income | 498.38M | 412.85M | 349.29M | 261.53M | 325.35M | 860.30M | 848.32M | 827.33M | 246.37M | 296.95M | 29.07M |
| Interest Expense | 11.34B | 7.46B | 2.95B | 1.36B | 1.27B | 1.11B | 968.49M | 935.85M | 345.02M | 0.00 | 135.68M |
| Depreciation & Amortization | 13.26B | 12.67B | 10.77B | 9.99B | 10.24B | 7.99B | 7.40B | 5.27B | 2.42B | 1.28B | 982.47M |
| EBITDA | 13.95B | -30.45B | 30.77B | 52.41B | 11.48B | 10.22B | 3.42B | 9.67B | 6.06B | 10.70B | 9.77B |
| EBITDA Ratio | 8.73% | 5.36% | 4.92% | 10.66% | 6.63% | 10.81% | 12.62% | 13.71% | 14.65% | 39.21% | 42.17% |
| Operating Income | 2.06B | -4.93B | -4.63B | 2.36B | -2.61B | 2.23B | 1.90B | 4.18B | 2.34B | 9.43B | 8.79B |
| Operating Income Ratio | 1.29% | -3.41% | -3.71% | 2.04% | -2.26% | 2.35% | 2.57% | 6.06% | 7.20% | 34.51% | 37.93% |
| Total Other Income/Expenses | -25.29B | -45.67B | 14.28B | 37.71B | 1.30B | 50.91B | -6.84B | -1.66B | 958.84M | -45.39M | 54.19M |
| Income Before Tax | -23.23B | -27.08B | 17.05B | 41.07B | -32.07M | 53.13B | -4.94B | 3.46B | 3.30B | 9.39B | 8.99B |
| Income Before Tax Ratio | -14.53% | -18.77% | 13.66% | 35.45% | -0.03% | 56.21% | -6.71% | 5.02% | 10.16% | 34.35% | 38.79% |
| Income Tax Expense | -2.54B | -4.78B | 4.92B | 8.52B | -643.26M | 11.68B | -1.37B | 614.66M | 538.41M | 1.88B | 1.42B |
| Net Income | -23.29B | -47.22B | 3.73B | 31.60B | 86.72M | 40.17B | -4.61B | 1.59B | 2.07B | 7.56B | 7.57B |
| Net Income Ratio | -14.56% | -32.72% | 2.99% | 27.28% | 0.08% | 42.50% | -6.25% | 2.30% | 6.36% | 27.67% | 32.68% |
| EPS | -583.58 | -1.10K | 88.78 | 758.88 | 2.08 | 965.42 | -114.04 | 39.60 | 53.54 | 220.75 | 249.25 |
| EPS Diluted | -583.58 | -1.10K | 88.68 | 758.45 | 2.08 | 964.63 | -114.04 | 39.60 | 53.54 | 220.75 | 249.25 |
| Weighted Avg Shares Out | 39.91M | 42.83M | 42.04M | 41.65M | 41.62M | 41.61M | 40.39M | 40.12M | 38.58M | 34.26M | 30.39M |
| Weighted Avg Shares Out (Dil) | 39.91M | 42.83M | 42.09M | 41.67M | 41.62M | 41.64M | 40.39M | 40.12M | 38.58M | 34.26M | 30.39M |
Source: https://incomestatements.info
Category: Stock Reports